Our data demonstrating that TCZ prevented the electrocardiographic abnormalities induced by IL-6 + AZM + HCQ suggest that targeting key molecules within the inflammatory cytokine storm such as IL-6, could be a novel strategy for limiting the direct electrophysiological and arrhythmogenic effects of IL-6 in COVID-19 patients26 and beyond. Here, IL6 is linked to COVID-19.